KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) EBT (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 120.41%
Dec 31, 2025 -52.79%
Sep 30, 2025 75.63%
Jun 30, 2025 -40.32%
Mar 31, 2025 1,597.71%
Dec 31, 2024 -89.56%
Sep 30, 2024 30.33%
Jun 30, 2024 111.17%
Mar 31, 2024 -787.93%
Dec 31, 2023 -21.67%
Sep 30, 2023 14.95%
Jun 30, 2023 -32.89%
Mar 31, 2023 49.00%
Dec 31, 2022 -15.84%
Sep 30, 2022 12.82%
Jun 30, 2022 16.06%
Mar 31, 2022 -9.20%
Dec 31, 2021 -13.86%
Sep 30, 2021 38.89%
Jun 30, 2021 -38.62%
Mar 31, 2021 124.21%
Dec 31, 2020 -563.05%
Sep 30, 2020 38.72%
Jun 30, 2020 635.20%
Mar 31, 2020 -135.66%
Dec 31, 2019 -109.56%
Sep 30, 2019 -24.04%
Jun 30, 2019 -10.26%
Mar 31, 2019 31.50%
Dec 31, 2018 -30.55%
Sep 30, 2018 319.15%
Jun 30, 2018 -70.94%
Mar 31, 2018 154.87%
Dec 31, 2017 -41.00%
Sep 30, 2017 -8.65%
Jun 30, 2017 -33.76%
Mar 31, 2017 80.02%
Dec 31, 2016 -30.34%
Sep 30, 2016 -3.47%
Jun 30, 2016 -2.42%
Mar 31, 2016 503.66%
Dec 31, 2015 -141.54%
Sep 30, 2015 1,798.08%
Jun 30, 2015 -96.41%
Mar 31, 2015 2,513.33%
Dec 31, 2014 -105.95%
Sep 30, 2014 125.00%
Jun 30, 2014 -54.52%
Mar 31, 2014 13.35%
Dec 31, 2013 6.23%
Sep 30, 2013 54.34%
Jun 30, 2013 -21.36%
Mar 31, 2013 31.38%
Dec 31, 2012 140.75%
Sep 30, 2012 -218.89%
Jun 30, 2012 -47.76%
Mar 31, 2012 27.16%
Dec 31, 2011 -12.90%
Sep 30, 2011 2.23%
Jun 30, 2011 1.30%
Mar 31, 2011 314.18%
Dec 31, 2010 -151.12%
Sep 30, 2010 1.38%
Jun 30, 2010 9.64%
Mar 31, 2010 10.00%
Dec 31, 2009 -15.65%
Sep 30, 2009 2.83%
Jun 30, 2009 27.36%